Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$2.40M
58.38K shares
What this filing means
FORDYCE MARSHALL plans to sell 58.38K shares of VERA THERAPEUTICS, INC. valued at approximately $2.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/12/2026ACC: 0001950047-26-004408
DirectorOfficer· President and CEO
Since May 2021
58.38K
Shares to sell
$2.40M
Approx. market value
18.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/12/2026
18.50KTotal acquired18.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/12/2026 | Exercise of Stock Options Cash | 18.50K | — |
| Total | 18.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
22.95K
Market value
$1.01M
4/14/2026
—Completed
Units to sell
16.93K
Market value
$710.6K
2/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.50K
Market value
$677.3K
5/12/2026
Total
Units
58.38K
Value
$2.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 22.95K | $1.01M | — | Completed |
2/23/2026 | 16.93K | $710.6K | — | Completed |
| Planned — Approximate Date | ||||
5/12/2026 | 18.50K | $677.3K | NASDAQ | Planned |
| Total | 58.38K | $2.40M | ||